Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19
- PMID: 35591884
- PMCID: PMC9112312
- DOI: 10.1177/20499361221095732
Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19
Abstract
SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) infection is being one of the most significant challenges of health care systems worldwide. Bacterial and fungal infections in hospitalized patients with coronavirus disease 2019 (COVID-19) are uncommon but consumption of antibiotics and antifungals has increased dramatically during the ongoing pandemic resulting in increased selective pressure for global antimicrobial resistance. Nosocomial bacterial superinfections appear to be more frequent than community-acquired coinfections, particularly among patients admitted to the intensive care unit (ICU) and those receiving immunosuppressive treatment. Fungal infections associated with COVID-19 might be missed or misdiagnosed. Existing and new antimicrobial stewardship (AMS) programmes can be utilized directly in COVID-19 pandemic and are urgently needed to contain the high rates of misdiagnosis and antimicrobial prescription. The aim of this review is to describe the role of bacterial and fungal infections and possible strategies of AMS to use in daily practice for optimal management of COVID-19.
Keywords: COVID-19; antimicrobial stewardship; bacterial infections; coinfections; fungal infections; secondary infections.
© The Author(s), 2022.
Conflict of interest statement
Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Similar articles
-
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530. Clin Infect Dis. 2020. PMID: 32358954 Free PMC article. Review.
-
State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.Infection. 2021 Aug;49(4):591-605. doi: 10.1007/s15010-021-01602-z. Epub 2021 Mar 11. Infection. 2021. PMID: 33709380 Free PMC article. Review.
-
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27. Clin Microbiol Infect. 2020. PMID: 32603803 Free PMC article.
-
The Dark Side of Nosocomial Infections in Critically Ill COVID-19 Patients.Life (Basel). 2023 Jun 17;13(6):1408. doi: 10.3390/life13061408. Life (Basel). 2023. PMID: 37374189 Free PMC article. Review.
-
Assessing the Impact of COVID-19 on Antimicrobial Stewardship Activities/Programs in the United Kingdom.Antibiotics (Basel). 2021 Jan 23;10(2):110. doi: 10.3390/antibiotics10020110. Antibiotics (Basel). 2021. PMID: 33498716 Free PMC article.
Cited by
-
Pulmonary Co-Infections Detected Premortem Underestimate Postmortem Findings in a COVID-19 Autopsy Case Series.Pathogens. 2023 Jul 12;12(7):932. doi: 10.3390/pathogens12070932. Pathogens. 2023. PMID: 37513779 Free PMC article.
-
Incidence and Risk Factors of Secondary Infections in Critically Ill SARS-CoV-2 Patients: A Retrospective Study in an Intensive Care Unit.Biomedicines. 2025 May 29;13(6):1333. doi: 10.3390/biomedicines13061333. Biomedicines. 2025. PMID: 40564052 Free PMC article.
-
Invasiveness of Ventilation Therapy Is Associated to Prevalence of Secondary Bacterial and Fungal Infections in Critically Ill COVID-19 Patients.J Clin Med. 2022 Sep 5;11(17):5239. doi: 10.3390/jcm11175239. J Clin Med. 2022. PMID: 36079168 Free PMC article.
-
MICROBIAL PATTERNS AND DRUG SENSITIVITY TEST OF BACTERIAL AND FUNGAL INFECTION IN COVID-19 PATIENTS AT THE NATIONAL REFERRAL HOSPITAL IN NORTH SUMATRA, INDONESIA.Afr J Infect Dis. 2024 Oct 25;19(1):36-44. doi: 10.21010/Ajidv19i1.5. eCollection 2025. Afr J Infect Dis. 2024. PMID: 39618541 Free PMC article.
-
Biochemical and metabolomic insights into antifungal mechanism of berberine against Candida glabrata.Appl Microbiol Biotechnol. 2023 Oct;107(19):6085-6102. doi: 10.1007/s00253-023-12714-x. Epub 2023 Aug 9. Appl Microbiol Biotechnol. 2023. PMID: 37555948
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous